Strantel Plus XL Tablets for Dogs

국가: 영국

언어: 영어

출처: VMD (Veterinary Medicines Directorate)

유효 성분:

Febantel, Praziquantel, Pyrantel Embonate

제공처:

Chanelle Pharmaceuticals Manufacturing Ltd

ATC 코드:

QP52AA51

INN (국제 이름):

Febantel, Praziquantel, Pyrantel Embonate

약제 형태:

Tablet

처방전 유형:

NFA-VPS - Non-Food Animal – Veterinarian, Pharmacist, Suitably Qualified Person

치료 그룹:

Dogs

치료 영역:

Anthelmintic

승인 상태:

Authorized

승인 날짜:

2012-10-30

제품 특성 요약

Revised: June 2023
AN: 00390/2022
Page 1 of 8
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Strantel Plus XL Tablets for Dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCES:
Praziquantel
175 mg
Pyrantel Embonate
504 mg (equivalent to 175 mg pyrantel)
Febantel
525 mg
EXCIPIENTS:
QUALITATIVE COMPOSITION OF EXCIPIENTS AND OTHER CONSTITUENTS
Lactose monohydrate,
Microcrystalline cellulose,
Magnesium stearate,
Colloidal anhydrous silica,
Croscarmellose sodium,
Sodium laurilsulfate
Pork flavour
A yellow coloured oblong tablet with a breakline on both sides.
The tablets can be divided into two equal parts.
3.
CLINICAL INFORMATION
3.1
TARGET SPECIES
Dogs.
3.2
INDICATIONS FOR USE FOR EACH TARGET SPECIES
In adult dogs: Treatment of mixed infections by nematodes and cestodes
of the
following species
NEMATODES:
ASCARIDS: _Toxocara canis_, _Toxascaris leonina_ (adult and late
immature forms).
HOOKWORMS: _Uncinaria stenocephala_, _Ancylostoma caninum_ (adults).
Revised: June 2023
AN: 00390/2022
Page 2 of 8
WHIPWORMS: _Trichuris vulpis_ (adults).
CESTODES:
TAPEWORMS: _Echinococcus_ species, _(E. granulosus, E.
multilocularis), Taenia_
species,
_(T. hydatigena, T. pisiformis, T. taeniformis), Dipylidium caninum_
(adult and
immature forms).
3.3
CONTRAINDICATIONS
Do not use simultaneously with piperazine compounds.
Do not use in cases of hypersensitivity to the active substances or to
any of the
excipients.
3.4
SPECIAL WARNINGS
Fleas serve as intermediate hosts for one common type of tapeworm –
Dipylidium caninum. Tapeworm infestation is certain to reoccur unless
control
of intermediate hosts such as fleas, mice, etc. is undertaken.
Care should be taken to avoid the following practices because they
increase
the risk of development of resistance and could ultimately result in
ineffective
therapy:
•
Too frequent and repeated use of anthelmintics from the same class,
over
an extended period of time.
•
Underdosing, which may be due to underestimation of body w